Skip to content

Clinical trials

Completed Pulmonary Disease, Chronic Obstructive trials in New Zealand

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Disease, Chronic Obstructive Status: Completed Country / region: New Zealand Clear all

53 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20031
20052
20067
20071
20087
20093
20103
20115
20124
20134
20144
20152
20162
20192
20202
20212

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed53

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim12
GlaxoSmithKline11
AstraZeneca7
Pearl Therapeutics, Inc.6
Novartis3
Mundipharma Research Limited2
Mylan Inc.2
Aquinox Pharmaceuticals (Canada) Inc.1
Fisher and Paykel Healthcare1
Flinders University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Disease, Chronic Obstructive53
Bronchitis, Chronic4
Asthma3
Emphysema3
Lung Diseases2
Bronchial Diseases1
Cardiovascular Diseases1
Dyspnea1
Inflammation1
Lung Diseases, Obstructive1

Trials

Showing 1 to 25 of 53. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.